Your browser doesn't support javascript.
loading
"Tumor-free survival" Does Not Outweigh the Adverse Effects of Anti-EGFR Therapy and Chemotherapy in Patients With NSCLC.
Zheng, Mei-Mei; Wu, Yi-Long.
Affiliation
  • Zheng MM; Guangdong Lung Cancer Institute, Guangdong Provincial Peoples Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China; Guangdong Cardiovascular Institute, Guangdong Provincial Peoples Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China.
  • Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial Peoples Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China. Electronic address: syylwu@live.cn.
J Thorac Oncol ; 19(8): 1146-1150, 2024 Aug.
Article in En | MEDLINE | ID: mdl-39112001
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2024 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / ErbB Receptors / Lung Neoplasms Limits: Humans Language: En Journal: J Thorac Oncol Year: 2024 Document type: Article